← Leaderboards
Yiyu Zou
Albert Einstein College Of Medicine
$1,384,420
Attributed
$2,520,179
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $483.7K · FY2006–16$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,520,179 · 2
By mechanism
R01$2,271,518 · 1
R21$248,661 · 1
Top collaborators
- Roman Perez-Soler6 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Ulrich Steidl$14,632,610
- Jessie Larios-Valencia$212,958
- Ilir Agalliu$346,638
- Britta Will$4,590,997
Others in their field
Top investigators on “Cessation Of Life”
- David R. Weir · University Of Michigan At Ann Arbor$345,522,974
- John M Lachin · George Washington University$134,302,892
- David M Nathan · Massachusetts Institute Of Technology$127,791,564
- Judith S Hochman · New York University School Of Medicine$112,898,313
- Jeffrey H Samet · Boston University Medical Campus$91,739,367
- Judith S. Currier · University Of California Los Angeles$85,330,415
Research focus
Cessation Of LifeStagingToxic EffectDoseGenesNeoplastic CellRouteCancer ModelCarcinogenesisExhalationExperimental ModelsAzacitidineHypermethylationEpigenetic ProcessDysmyelopoietic SyndromesGene SilencingChronicBronchial EpitheliumBiologicalClinical EfficacyCancer EtiologyEarly DiagnosisCytotoxicBreathing
Grant awards (8)
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$442,325
R01 · FY2016 · CA
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$53,995
R01 · FY2015 · CA
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$483,713
R01 · FY2014 · CA
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$472,671
R01 · FY2013 · CA
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$402,645
R01 · FY2012 · CA
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy$416,169
R01 · FY2011 · CA
A Tumor Specific Therapy Approach for Small Cell Lung Cancer$122,501
R21 · FY2007 · CA · contact PI
A Tumor Specific Therapy Approach for Small Cell Lung Cancer$126,160
R21 · FY2006 · CA · contact PI